Katie Soper1, Giuseppina Di Meglio2. 1. Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. 2. Division of Adolescent Medicine, Montreal Children's Hospital, Montreal, Quebec, Canada.
Abstract
OBJECTIVE: Access to effective contraceptives, including emergency contraception (EC), is critical to reducing unintended adolescent pregnancy. This study evaluates the accessibility of Ln-EC (levonorgestrel EC) for adolescents in Quebec community pharmacies. METHODS: We conducted an anonymous self-administered electronic survey of Quebec community pharmacists between June 1, 2016 and October 31, 2016. Pharmacists were asked about the availability of Ln-EC in their pharmacy, whether they prescribed Ln-EC, and their experience with adolescents who requested Ln-EC. RESULTS: Five hundred and ninety-one pharmacists responded, with representation from across the province. Ninety-five per cent had Ln-EC in stock. Most pharmacists (90%) reported being comfortable prescribing Ln-EC, though they were less comfortable prescribing to adolescents than to adults (*P<0.001). Pharmacists also reported that cost and confidentiality are barriers to accessing Ln-EC for some adolescents. CONCLUSIONS: This study indicates that availability and pharmacist comfort are not likely to be barriers to Ln-EC use for adolescents. On the other hand, cost and/or confidentiality do represent a barrier for some adolescents. This study lays the groundwork for a national study examining the accessibility of EC for adolescents.
OBJECTIVE: Access to effective contraceptives, including emergency contraception (EC), is critical to reducing unintended adolescent pregnancy. This study evaluates the accessibility of Ln-EC (levonorgestrel EC) for adolescents in Quebec community pharmacies. METHODS: We conducted an anonymous self-administered electronic survey of Quebec community pharmacists between June 1, 2016 and October 31, 2016. Pharmacists were asked about the availability of Ln-EC in their pharmacy, whether they prescribed Ln-EC, and their experience with adolescents who requested Ln-EC. RESULTS: Five hundred and ninety-one pharmacists responded, with representation from across the province. Ninety-five per cent had Ln-EC in stock. Most pharmacists (90%) reported being comfortable prescribing Ln-EC, though they were less comfortable prescribing to adolescents than to adults (*P<0.001). Pharmacists also reported that cost and confidentiality are barriers to accessing Ln-EC for some adolescents. CONCLUSIONS: This study indicates that availability and pharmacist comfort are not likely to be barriers to Ln-EC use for adolescents. On the other hand, cost and/or confidentiality do represent a barrier for some adolescents. This study lays the groundwork for a national study examining the accessibility of EC for adolescents.
Authors: Olivia Sampson; Sandy K Navarro; Amna Khan; Norman Hearst; Tina R Raine; Marji Gold; Suellen Miller; Heike Thiel de Bocanegra Journal: Perspect Sex Reprod Health Date: 2009-06
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Amanda Black; Edith Guilbert; Dustin Costescu; Sheila Dunn; William Fisher; Sari Kives; Melissa Mirosh; Wendy V Norman; Helen Pymar; Robert Reid; Geneviève Roy; Hannah Varto; Ashley Waddington; Marie-Soleil Wagner; Anne Marie Whelan; Carrie Ferguson; Claude Fortin; Maria Kielly; Shireen Mansouri; Nicole Todd Journal: J Obstet Gynaecol Can Date: 2015-10